Notice of Extraordinary General Meeting in Aerocrine AB
The shareholders of Aerocrine AB (publ) are hereby invited to attend the Extraordinary General Meeting to be held at 4.00 p.m. on Thursday 21 October 2010 at Sundbybergsvägen 9 in Solna.
Right to Attend and Notice of Attendance
Shareholders who wish to attend the EGM must be recorded in the share register maintained by Euroclear Sweden AB on Friday 15 October 2010 and notify the company of their intent to participate in the EGM no later than Monday 18 October 2010, preferably before 3.00 p.m. The notice of attendance is made by post to Aerocrine AB, Sundbybergsvägen 9, 171 21 Solna, Sweden, or by telephone +46 08‑629 07 80, or by telefax +46 08-629 07 81 or by email, info@aerocrine.com. On giving notice of attendance, name, personal identity number or corporate identity number, address and telephone number shall be stated. The same time and addresses apply to notice of the number of attending assistants. Proxy, registration certificates and other certificates of authorisations must be available at the EGM, and may preferably be sent to the company together with the notice of attendance. Any proxy shall be presented in original and must not be older than one year. A form of proxy is available on the company’s website www.aerocrine.comhttp://www.aerocrine.com/ and may also be ordered from the company at the above address.
Shareholders having their shares registered in the name of a nominee must, in order to be entitled to participate in the EGM, request to have the shares registered in their own name on Friday 15 October 2010. Such registration may be temporary.
Agenda of the Meeting
The Board’s Proposal for Agenda
1. Opening of the Meeting
2. Election of Chairman of the Meeting
3. Preparation and approval of the voting list
4. Approval of the agenda
5. Election of one or two minutes-checkers
6. Determination whether the Meeting has been properly convened
7. Election of board member
8. Closing of the Meeting
Election of board member (item 7)
In light of Novo A/S having become a major shareholder of the company through the directed share issue resolved by the Board on 15 September 2010 by virtue of the authorisation by the general meeting, and that Lars Gatenbeck in connection with the EGM will retire from the Board, shareholders representing approximately 58.4 percent of the shares and votes in the company have proposed that Scott Beardsley is elected new ordinary Board member. The nomination committee has informed their support of the proposal.
Scott Beardsley (born 1967) holds a MBA from UCLA’s Anderson Graduate School of Management and a Bachelor of Science in business administration. Since 2009, Beardsley is a senior partner of Novo Growth Equity, a division within Novo A/S, and previously inter alia led Piper Jaffray’s American biopharmaceutical investment banking practice and was a member of the Health Care Group at Montgomery Securities.
General
At the time of this notice the total number of shares and votes in the company amounts to 82,724,026.
Solna in October 2010
Aerocrine AB (publ)
The Board of Directors
For more information, contact:
Paul de Potocki, CEO, telephone: +46 8 629 07 80
Michael Colérus, CFO, telephone: +46 8 629 07 85
About Aerocrine Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. The pioneer and leader in the technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX® Flex. Both products enable the fast and reliable measurement of airway inflammation and may thus play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine is based in Sweden with subsidiaries in the US, Germany and the UK. Aerocrine shares were listed on the Stockholm Stock Exchange on 15 June 2007. Aerocrine may be required to disclose the information provided herein pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 am on October the 5th 2010.